|
|
Other links at Articles > Hematology-Oncology |
| 1. |
Does Switch Maintenance Benefit Patients With NSCLC?
|
|
|
In patients with partial response to initial therapy, is there benefit to switching to a new agent for maintenance therapy? Dr. Mark Kris examines studies that address this question. Medscape Hematology-Oncology
|
|
|